Although this pre-clinical model is of use to study the interactions between the intestinal microbiome and spontaneous colitis, NEMO-deficient patients exhibit a variety of mucocutaneous diseases, and it is feasible that they may also carry concomitant mutations in IBD-associated genes [100]. The gene discussed is IKBKG; the disease is inflammatory bowel disease.